Endothelial dysfunction in COVID-19 induces a prothrombotic endothelial state, characterized by increased expression of tissue factor, von Willebrand factor, and impaired thrombomodulin and antithrombin activity, promoting coagulation activation and thrombus formation37. This evidence concerns the gene THBD and COVID-19.